Randomized, Double-Blind, Placebo-Controlled Study Of Pregabalin In Patients With Fibromyalgia
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
This study, will compare pregabalin with placebo for the duration of 15 weeks to evaluate the
efficacy and safety of pregabalin in patients with fibromyalgia.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.